Temlyakova Julia Rafikovna

• From 2007 to 2013. "Ural State Medical Academy", specialty "medical business".
• From 2013 to 2014, MBU TSGK No. 7, Department of faculty therapy, internship in the specialty "Therapy".
• In 2014 - Department of Therapy, Hematology and Transfusiology of the Faculty of Advanced Training and Professional Retraining of Doctors of the Novosibirsk State Medical University of the Ministry of Health of the Russian Federation, primary specialization "Hematology".
• In 2019 - SOCB No. 1, Department of Hematology and Transfusiology, advanced training in the specialty “Hematology”.
• In 2024, the "Russian Medical Academy of Continuing Professional Education" of the Ministry of Health of the Russian Federation, advanced training in the specialty “Hematology”.

Work experience:

• From 2014 to 2019 - MBU TSGB No. 7, Department of Hematology and Chemotherapy, hematologist.
• From 2019 to 2021 - R.M. Gorbacheva Institute of Pediatric Hematology and Transplantology, Department of Chemotherapy and Bone Marrow Transplantation, hematologist.
• From 2021 to 2024 MMCC Kommunarka DZM, Department of Hematology and Chemotherapy No. 1, hematologist.
• From 2024 to the present – MCSC named after. Loginova, Department of Bone Marrow Transplantation, Hematopoietic Stem cells and High-dose chemotherapy, hematologist.

Professional skills:

• Guiding the principles of high-dose chemotherapy, immunotherapy.
• Accompanying therapy and correction of complications in the treatment of oncohematological diseases.
• Performing diagnostic and therapeutic-diagnostic manipulations: trepanobiopsy of the iliac bone, aspiration biopsy of the bone marrow, lumbar puncture with intrathecal administration of cytostatics.
• Experience in managing patients on an outpatient basis and in a round-the-clock hematological hospital.

Professional interests:

• The study of changes in the patient's microbiome of the hematological profile
• The place and role of transplantation of fecal microbiota in overcoming antibacterial resistance of severe infectious complications
• A multidisciplinary approach in the treatment of malignant lymphomas associated with secondary immunodeficiency, including HIV infection.
• Treatment of patients with acute leukemia of various cellular orientation